All Type of News
Highly expected M&As were not able to reform the pharmaceutical industry
The prospect that gigantic M&Aswere going to be made in 2014 has escaped. Thus, M&As that can shake the pharmaceutical industry will move to the next year.
According to the industry concerned, listed pharmaceutical c...
The Celgene’s anticancer drug ‘Revlimid’ has the lowest margin, which created more financial damages to sellWhile the Korea Pharmaceutical Distribution Association is fighting a margin war with pharmaceutical companies, another low margin product has become an issue in the industry.
...
|
The Korea Pharmaceutical Association opposed on the extensive policy about the animal medicine manager
As an opinion brought up to add veterinarians and medical technologists as wholesale managers dealing with animal medicines, the Korean Pharmaceutical Associationdecided to strongly oppose to the opinion.
The Korean ...
Pharmaceutical public-relation officers are making continuous promotions… the importance of communication has been raised
It has become a trend that pharmaceutical public-relation officers are promoting to board members. The trend grabbed the industry’s attention because it is not just a simple promotion, but a promotion to a board membe...
Due to conflicts between doctors and pharmacists over the generic substitution, pharmaceutical businessmen are the one suffering in-between
Conflicts between doctors and pharmacists over the generic substitution are causing hardship on blameless pharmaceutical businessmen.
Especially, businessmen dealing with clinic-level medical institutions are having ...
The Regulation Guillotine has created two different responses in the healthcare industry
As the government disclosed the Regulation Guillotine, including the chiropractic qualification, the tattooist legalization, and the extensive use of modern medical equipment for oriental doctors, the pharmaceutical i...
Large-selling pharmaceutical products will be expired in 2015
As the pharmaceutical industry has focused on patent-expiring pharmaceutical products due to the Patent Linkage System, which will be enforced soon, it is known that blockbuster-level pharmaceutical products are expec...
Boryung Pharmaceutical and Roche will co-promote the hepatitis type B and C treatment ‘Pegasys’
Boryung Pharmaceutical and Roche Korea will co-promote the chronic hepatitis type B and C treatment ‘Pegasys’.
Boryung Pharmaceutical (CEO Tae-hong Choi) and Roche Korea (General Manager Mike Crichton) announced on t...
The four-strain seasonal influenza vaccine ‘Fluarix Tetra’ is approved for the first time in Korea
The Ministry of Food and Drug Safety approved sales of the GSK’s four-strain influenza vaccine ‘Fluarix Tetra’ for the first time in Korea. It is expected that its launch will be made in the second half of the next ye...
The HIRA extended to disclose non-benefit medical expenses with a wider range
The Health Insurance Review & Assessment Service (HIRA) additionally disclosed non-benefit medical expenses of general hospitals having less than 300 sickbeds and dental clinics attached to dental schools on the 30th....
